Clinical trial
Long-term Study of YM178: Long Term Study of YM178 in Subjects With Overactive Bladder
NCT00840645 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Study of YM178: Long Term Study of YM178 in Subjects With Overactive Bladder
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- March 31, 2010
- Enrollment
- 204 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.